Newsbenzinga
Novo Nordisk Loses Court Bid Against Eli Lilly’s Weight-Loss Drug Ads — Judge Says Sales Impact Was Negligible (UPDATED)
· Published
Article summary
Novo Nordisk fails to block Eli Lilly’s weight-loss drug ads as a judge finds little evidence of market impact or lasting harm.
An excerpt from the original article.
Comments —
Loading comments…